Nathan Abdelsayed, MD
Pain Management · West Covina
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 8 years
- Graduated 2018
Offices
1 location · Emanate Health Medical Care Foundation · 85 clinicians in this group
Hospitals listed: Casa Colina Hospital · Emanate Health Foothill Presbyterian Hospital · Emanate Health Inter-Community Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Abdelsayed’s office at (626) 732-8390 to ask if they take your plan before you enroll.
California Medical Board record
Licence A179754 · Current
Licensed to practise in California · since 2022 · expires 2028-06-30 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Physical Medicine and Rehabilitation - Pain Medicine
- American Board of Physical Medicine and Rehabilitation - Physical Medicine and Rehabilitation
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Casa Colina HospitalPomona, CAAcute Care Hospital · Voluntary non-profit - Private · No emergency department79% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Emanate Health Foothill Presbyterian HospitalGlendora, CAAcute Care Hospital · Voluntary non-profit - Private · No emergency departmentPart of Emanate Health, which runs 3 hospitalsPatients rate it 2 of 5 · 63% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025
- Emanate Health Inter-Community HospitalCovina, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Emanate Health, which runs 3 hospitalsPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Casa Colina Hospital
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 5 the same, 0 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.08) · 111 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.43 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 29 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 221 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 429 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 432 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.22 (0.68 to 5.75) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.58 (0 to 3.27) · 153 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.52 (0.83 to 4.21) · 202 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.92 (0 to 15.66) · 148 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.74 (1.56 to 9.92) · 123 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.76 (0.23 to 3.28) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.47 (0 to 1.63) · 334 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 26 cases | None | Apr 2023 – Mar 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -53.5 · 29 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 39 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.3 to 16.6) · 359 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 173 cases | No different | Jan 2024 – Dec 2024 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 71% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 83% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Emanate Health Foothill Presbyterian Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0 to 2) · 475 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.74 to 1.58) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.2 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 43 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 108 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.7 · 64 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.7 · 1,404 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 2,452 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.57 (1.08 to 6.06) · 286 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 71 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.51 (0.83 to 4.19) · 283 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.99 (1.35 to 20.62) · 77 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.86 (1.63 to 10.08) · 56 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.97 (0.06 to 1.88) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.662 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.026 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 44 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 234 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.2 · 139 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 308 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.1 · 520 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 85 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9 to 16.2) · 293 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 174 cases | No different | Jan 2024 – Dec 2024 |
What patients said (582 patients answered, 16% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 52% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 65% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 63% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Emanate Health Inter-Community Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 2 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.4 (0.39 to 2.4) · 990 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.53 to 1.18) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.56 (145.92 to 251.21) · 69 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 99 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.8 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 279 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 665 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.3 · 389 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.1 · 3,599 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,844 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.42) · 6,958 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.21 (0.98 to 5.43) · 1,118 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.46 (0 to 3.08) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.05 (0.53 to 3.58) · 1,140 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.68 (1.69 to 15.67) · 450 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.07 (1.14 to 9) · 397 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.17) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 0.97) · 5,698 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 213 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.578 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.853 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.438 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.205 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 352 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 631 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -2 · 136 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.5 · 336 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.2 · 731 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 1,007 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.5 to 8) · 53 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (8.8 to 16.5) · 53 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.4 · 191 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 188 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.6) · 113 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 106 cases | No different | Jan 2024 – Dec 2024 |
What patients said (924 patients answered, 12% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 77% |
| Doctors "always" explained things so they could understand | 64% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 66% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$44,557
Medicare paid this office $44,557 for 144 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 39 | $8,207 | $80 |
| New patient visit (45+ min) | 66 | $7,242 | $110 |
| Short return visit (20+ min) | 62 | $5,453 | $55 |
| New patient visit (30+ min) | 58 | $3,787 | $65 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 17 | $3,114 | $111 |
See all 12 services
| Return visit (30+ min) | 39 | $8,207 | $80 |
| New patient visit (45+ min) | 66 | $7,242 | $110 |
| Short return visit (20+ min) | 62 | $5,453 | $55 |
| New patient visit (30+ min) | 58 | $3,787 | $65 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 17 | $3,114 | $111 |
| Injection of substance into lower spine canal using imaging guidance | 29 | $3,056 | $83 |
| Short return visit | 35 | $1,398 | $29 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 21 | $1,358 | $52 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 12 | $1,245 | $83 |
| Aspiration and/or injection of fluid from large joint | 20 | $935 | $43 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 13 | $876 | $46 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $138 | $10 |
Procedures year by year
| Procedure | 2023 | 2024 |
|---|---|---|
| Injection of substance into lower spine canal using imaging guidance | – | 37 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | – | 28 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | – | 26 |
| Aspiration and/or injection of fluid from large joint | – | 22 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | – | 19 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | – | 15 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
144 Original Medicare patients in 2024. Average age 74 · Under 65 10% · 85 and older 15% · Women 61% · Also on Medicaid 49% · Health risk score 1.66. Above the middle of the specialty; the typical pain management clinician is at 1.38.
Conditions among them: High blood pressure 75% · Diabetes 49% · Coronary heart disease 32% · Chronic kidney disease 31% · Depression 25% · COPD 19% · Heart failure 17% · Atrial fibrillation 17% · Cancer 14%.
The office billed $165,636, Medicare allowed $56,073 and paid $44,557; for 628 services of 40 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 144 | 628 | 74 | 1.66 | $165,636 | $44,557 |
| 2023 | 15 | 30 | 74 | 1.97 | $9,098 | $2,427 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| New patient visit (45+ min) | 11 | $1,227 | $112 |
Medicaid work
$520 in 2024
Medicaid paid $520 for 13 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 13 | $520 |
| 2024 | 13 | 1 | 13 | $520 |
Drugs they prescribed that Part D paid
$10,354
Pharmacies billed $10,354 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 21% of their Part D prescriptions (177 of 856) in 2024. At or below the middle of the specialty; the typical pain management clinician is at 44%.
854 generic and fewer than 11 brand-name prescriptions · $10,354 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Pregabalin | 115 | $2,467 | $21 |
| Gabapentin | 225 | $1,812 | $8 |
| Oxycodone | 30 | $1,012 | $34 |
| Naloxone | 13 | $861 | $66 |
| Oxycodone-Acetaminophen | 53 | $786 | $15 |
See all 12 drugs
| Pregabalin | 115 | $2,467 | $21 |
| Gabapentin | 225 | $1,812 | $8 |
| Oxycodone | 30 | $1,012 | $34 |
| Naloxone | 13 | $861 | $66 |
| Oxycodone-Acetaminophen | 53 | $786 | $15 |
| Hydrocodone-Acetaminophen | 63 | $683 | $11 |
| Duloxetine | 63 | $653 | $10 |
| Cyclobenzaprine | 50 | $536 | $11 |
| Tizanidine | 22 | $481 | $22 |
| Methocarbamol | 91 | $195 | $2 |
| Tramadol | 26 | $141 | $5 |
| Meloxicam | 34 | $48 | $1 |
Year by year
| 2024 | 856 | 161 | 21% (177) | None | $10,354 |
| 2023 | 269 | 131 | 26% (71) | None | $5,551 |
| 2022 | 204 | 114 | 28% (58) | None | $3,933 |
| 2021 | 262 | 51 | 8% (22) | None | $10,865 |
| 2020 | 288 | 57 | 8% (22) | None | $19,063 |
| 2019 | 135 | 20 | 0% (0) | None | $9,860 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Gabapentin | 75 | $1,011 | $13 |
| Hydrocodone-Acetaminophen | 22 | $472 | $21 |
| Oxycodone-Acetaminophen | 19 | $380 | $20 |
| Duloxetine | 16 | $293 | $18 |
| Methocarbamol | 23 | $273 | $12 |
| Oxycodone | 14 | $249 | $18 |
| Pregabalin | 12 | $228 | $19 |
| Tizanidine | 19 | $219 | $12 |
| Cyclobenzaprine | 11 | $53 | $5 |
| Diazepam | 16 | $12 | $1 |
2022: 5 drugs
| Hydrocodone-Acetaminophen | 23 | $633 | $28 |
| Gabapentin | 44 | $507 | $12 |
| Oxycodone-Acetaminophen | 12 | $214 | $18 |
| Tramadol | 12 | $64 | $5 |
| Diazepam | 21 | $31 | $1 |
2021: 4 drugs
| Baclofen | 20 | $965 | $48 |
| Gabapentin | 31 | $384 | $12 |
| Famotidine | 12 | $83 | $7 |
| Oxycodone | 14 | $59 | $4 |
2020: 3 drugs
| Gabapentin | 14 | $95 | $7 |
| Oxycodone | 18 | $87 | $5 |
| Atorvastatin | 11 | $65 | $6 |
Money from drug and device companies
$992 in 2025
| 2025 | 9 | 20 | None | $992 |
| 2024 | 6 | 30 | None | $2,002 |
| 2023 | 4 | 28 | None | $4,944 |
| 2022 | 2 | 5 | None | $102 |
| 2021 | 2 | 2 | None | $1,229 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Intracept | $459 | 8 payments
|
| SPR Therapeutics | Sprint Pns System | $152 | 1 payment
|
| Abbott Laboratories | Eterna | $150 | 2 payments
|
| Lilly USA | Mounjaro | $59 | 2 payments
|
| Stryker | Flowtriever Catheter, S | $58 | 2 payments
|
| Abbvie | Qulipta | $43 | 2 payments
|
See all 20 published payments
| Abbott Laboratories | Meals · 2025-11-21 | Eterna | $117 |
| Medtronic | Meals · 2025-11-20 | Inceptiv | $26 |
| Vertex Pharmaceuticals | Meals · 2025-11-06 | Journavx | $26 |
| Boston Scientific | Meals · 2025-10-16 | Wavewriter Alpha Prime 16 | $9 |
| Abbvie | Meals · 2025-10-14 | Qulipta | $27 |
| Boston Scientific | Meals · 2025-09-19 | Intracept | $174 |
| Boston Scientific | Meals · 2025-09-18 | General - Pain Management | $104 |
| Boston Scientific | Meals · 2025-09-18 | Wavewriter Alpha Prime 16 | $17 |
| Boston Scientific | Meals · 2025-08-11 | Wavewriter Alpha Prime 16 | $108 |
| Boston Scientific | Meals · 2025-07-18 | General - Pain Management | $20 |
| Boston Scientific | Meals · 2025-07-18 | General - Pain Management | $5 |
| Boston Scientific | Meals · 2025-07-03 | Wavewriter Alpha Prime 16 | $21 |
| Abbott Laboratories | Meals · 2025-06-24 | Proclaim | $34 |
| Lilly USA | Meals · 2025-06-10 | Mounjaro | $28 |
| Stryker | Meals · 2025-05-08 | Flowtriever Catheter, S | $33 |
| Stryker | Meals · 2025-04-25 | Flowtriever Catheter, S | $25 |
| GlaxoSmithKline | Meals · 2025-03-31 | Shingrix | $19 |
| Lilly USA | Meals · 2025-03-20 | Mounjaro | $31 |
| SPR Therapeutics | Meals · 2025-02-28 | Sprint Pns System | $152 |
| Abbvie | Meals · 2025-02-19 | Botox | $16 |
See earlier years (2024, 2023, 2022, 2021)
2024: $2,002
| Medtronic | Intellis Adaptivestim | $1,132 | 12 payments
|
| Abbott Laboratories | Proclaim | $685 | 12 payments
|
| SPR Therapeutics | Sprint Pns System | $108 | 2 payments
|
| Abbvie | Ubrelvy | $33 | 2 payments
|
| GlaxoSmithKline | Arexvy | $25 | 1 payment
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump With Control-Iq | $19 | 1 payment
|
2023: $4,944
| Abbott Laboratories | Proclaim | $4,698 | 24 payments
|
| Painteq | Painteq | $173 | 1 payment
|
| Pacira Pharmaceuticals | Iovera | $40 | 1 payment
|
| Abbvie | Botox | $32 | 2 payments
|
2022: $102
| Abbvie | Botox | $52 | 3 payments
|
| Medtronic | Intellis Adaptivestim | $49 | 2 payments
|
2021: $1,229
| Legacy Ortho | None | $1,200 | 1 payment
|
| Allergan | Botox | $29 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 79.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1295230142
- Licence
- CA A179754California A179754: Current · expires 2028-06-30
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 208VP0000X (208VP0000X)
- Mailing address
- 200 S Prospect Ave, Redondo Beach, CA, 90277
- NPI first listed
- 2018-03-23
- NPI last updated
- 2024-08-20
- NPI record certified
- 2024-08-20
This is when the NPI record was last certified, not a medical board exam.